401 related articles for article (PubMed ID: 20432728)
1. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
Sharma P; Gupta P; Gupta N; Suri V; Rajwanshi A
Turk Patoloji Derg; 2021; 37(1):32-38. PubMed ID: 33372263
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases.
Ucak R; Dilbaz OF; Polat N
Acta Cytol; 2024; 68(1):54-59. PubMed ID: 38320537
[TBL] [Abstract][Full Text] [Related]
4. Difference Between Cryotherapy and Follow Up Low Grade Squamous Lesion of Cervix Uteri.
Jahic M; Jahic E; Mulavdic M; Hadzimehmedovic A
Med Arch; 2017 Aug; 71(4):280-283. PubMed ID: 28974850
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
[TBL] [Abstract][Full Text] [Related]
7. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
Castle PE; Glass AG; Rush BB; Scott DR; Wentzensen N; Gage JC; Buckland J; Rydzak G; Lorincz AT; Wacholder S
J Clin Oncol; 2012 Sep; 30(25):3044-50. PubMed ID: 22851570
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
[TBL] [Abstract][Full Text] [Related]
9. [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
Luo GP; Zeng X; Cao HY; Tang D; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):516-522. PubMed ID: 34018374
[TBL] [Abstract][Full Text] [Related]
10. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.
Possati-Resende JC; Fregnani JH; Kerr LM; Mauad EC; Longatto-Filho A; Scapulatempo-Neto C
PLoS One; 2015; 10(7):e0134445. PubMed ID: 26230097
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
Bruno MT; Ferrara M; Fava V; Barrasso G; Panella MM
Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus infection in abnormal pap smears.
Mishra J; Kalantri S; Raphael V; Dey B; Khonglah Y; Das A
Cytojournal; 2023; 20():21. PubMed ID: 37681080
[TBL] [Abstract][Full Text] [Related]
13. HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
Regauer S; Reich O; Kashofer K
Am J Surg Pathol; 2022 Feb; 46(2):147-158. PubMed ID: 34387215
[TBL] [Abstract][Full Text] [Related]
14. Optimising cervical cancer screening during pregnancy: a study of liquid-based cytology and HPV DNA co-test.
Gu L; Hu Y; Wei Y; Hong Z; Zhang Y; Lin J; Qiu L; Di W
Epidemiol Infect; 2024 Jan; 152():e25. PubMed ID: 38254272
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
[TBL] [Abstract][Full Text] [Related]
16. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
Liu S; Minaguchi T; Lachkar B; Zhang S; Xu C; Tenjimbayashi Y; Shikama A; Tasaka N; Akiyama A; Sakurai M; Nakao S; Ochi H; Onuki M; Matsumoto K; Yoshikawa H; Satoh T
PLoS One; 2018; 13(2):e0193061. PubMed ID: 29466435
[TBL] [Abstract][Full Text] [Related]
17. Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.
Arbyn M; Xu L; Verdoodt F; Cuzick J; Szarewski A; Belinson JL; Wentzensen N; Gage JC; Khan MJ
Ann Intern Med; 2017 Jan; 166(2):118-127. PubMed ID: 27842420
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Approach to Patients with Atypical Squamous Cells of Undetermined Significance Cytologic Findings on Cervix.
Jahic M; Jahic E
Med Arch; 2016 Jul; 70(4):296-298. PubMed ID: 27703293
[TBL] [Abstract][Full Text] [Related]
19. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
